Rheumatology Patient Registry and Biorepository

Last updated: March 3, 2025
Sponsor: Yale University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Systemic Lupus Erythematosus

Antiphospholipid Syndrome

Psoriatic Arthritis

Treatment

N/A

Clinical Study ID

NCT04402086
2000026608
No NIH funding
  • Ages 18-99
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Eligibility Criteria

Inclusion

Inclusion Criteria for Rheumatology Patients:

  • Patients ≥18 years old with a diagnosis of a rheumatic autoimmune disease including, but not limited to: adult onset Still's disease, ankylosing spondylitis, antiphospholipid syndrome, Behcet's disease, dermatomyositis, giant cell arteritis, mixed connective tissue disease, polymyalgia rheumatica, polymyositis, psoriatic arthritis, reactive arthritis, rheumatoid arthritis, sarcoidosis, scleroderma, Sjogren's syndrome, systemic lupus erythematosus, undifferentiated connective tissue disease and vasculitis.

  • Receiving clinical care at Yale Rheumatology clinics

Exclusion Criteria for Rheumatology Patients:

  • Unable to provide informed consent

  • No patients will be excluded based on gender or ethnicity or pregnancy status.

  • Women who are currently pregnant will need to wait to donate a skin biopsy until after they deliver.

  • Patients allergic to lidocaine or epinephrine or have a history of impaired wound healing will not be able to donate a skin biopsy.

Inclusion Criteria for Healthy Volunteers:

  • Age ≥ 18 years old

  • No chronic skin conditions

  • No diagnosis of a rheumatic autoimmune disease (e.g., lupus, rheumatoid arthritis)

  • Normal BMI

Exclusion Criteria for Healthy Volunteers:

  • Unable to provide informed consent.

  • Currently pregnant or nursing unless the study goal is to study pregnant or nursing woman.

  • Allergies to lidocaine or epinephrine (skin biopsies).

  • A history of impaired wound healing (skin biopsies).

Study Design

Total Participants: 5000
Study Start date:
August 04, 2020
Estimated Completion Date:
June 01, 2030

Study Description

A rheumatology biorepository will be created to permit comparative analyses between the rheumatic diseases in order to increase the understanding of disease pathogenesis. Patients seen at Yale clinics diagnosed with rheumatic diseases are invited to participate in this study. These rheumatic diseases include, but are not limited to: adult onset Still's disease, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, antiphospholipid syndrome, systemic lupus erythematosus, Behcet's disease, dermatomyositis, polymyositis, giant cell arteritis and other vasculitides, Lyme's disease, mixed connective tissue disease, polymyalgia rheumatica, rheumatoid arthritis, sarcoidosis, systemic sclerosis (scleroderma), Sjogren's syndrome, and undifferentiated connective tissue disease.

Connect with a study center

  • Yale New Haven Hospital

    New Haven, Connecticut 06510
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.